The Midwest Melanoma Partnership (MMP) is a multi-institutional group of physicians, scientists and patient advocates dedicated to the development of improved therapies for patients with malignant melanoma. The purpose of this activity is to promote collaborative clinical studies built upon the expertise of a multidisciplinary, multi-institutional team of scientists and physicians. The morning meeting sessions (only open to partnership members), will be followed by an afternoon CME conference on brain metastases from melanoma. This event is open to anyone with an interest in melanoma prevention, treatment and research. This multidisciplinary conference will provide clinicians with information on state-of-the-art treatment and diagnostic modalities, therapeutic management and clinical support issues, that are relevant to a unique and challenging patient population.
Following this program, participants should be able to:
ªOutline advances in melanoma pathobiology, diagnosis, risk stratification, and biomarkers
ªIdentify advances in the understanding of genetic and molecular markers for treatment of metastatic melanoma
ªUnderstand changes in the signs and symptom in a patient to diagnose metastasis to the brain even while undergoing treatment for systemic disease
ªAssess the influence genetic and molecular markers on choosing and personalizing therapy in patients with metastatic melanoma
ªDescribe how to select therapy, manage side effects, and assess response in patients being treated for brain metastatic melanoma
ªEvaluate data from melanoma clinical trials and novel clinical trial designs to bridge the gap of unmet needs in the melanoma field
Friday, April 12, 2013 9:00 AM - 5:00 PM
Buffalo Niagara Marriott1340 Millersport HighwayAmherst, NY 14221716-689-6900
Nikhil Khushalani, MD
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Roswell Park Cancer Institute and the Midwest Melanoma Partnership. Roswell Park Cancer Institute is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.
Roswell Park Cancer Institute designates this live educational activity for a maximum of 2.00 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Cvent Online Event Registration Software | Copyright © 2000-2013 Cvent Inc. All rights reserved.